Table 5.
Nanoplatform | Name | Therapeutic agent | Therapeutic application | Reference |
---|---|---|---|---|
Liposomes | Chol-SS-mPEG/HA-L | DOX | Chemotherapy | 491 |
Hydrogels | SP@MX-TOB/GelMA | Tobramycin (TOB) | Chemotherapy, photothermal therapy | 492 |
Chitosan |
ZSM-5/CS/DOX nanodisks |
DOX | Chemotherapy | 493 |
Nano-oxides | PEG-GOFA/ICG | DOX and TH287 | Chemotherapy, photodynamic therapy | 494 |
Nanocomposite oxides | β-TCP-Fe-GO | Fe3O4 magnetic particles | Hyperthermal therapy | 495 |
Nanometals and nanoalloys | Au@AgNRs@BSA |
Au and Ag nanoparticles |
Photothermal therapy | 496 |
Carbon nanotubes |
SWCNTs | Single-walled carbon nanotube | Chemotherapy | 497 |
Micelles | NP-PTX-DOX | PTX and DOX | Chemotherapy | 498 |
Dendritic macromolecules |
AG/G5-Dox NGs | DOX | Chemotherapy | 499 |
Nanocapsules | IFS-LNC | Ifosfamide | Chemotherapy | 500 |
Exosomes | EXO-DOX | DOX | Chemotherapy | 501 |